Chongqing Pharmaceutical Research Institute Co., Ltd. has received funding from the Bill & Melinda Gates Foundation for the development of a large-scale semi-synthetic Artemisinin processIn July 2018, Chongqing Pharmaceutical Research Institute Co., Ltd (“CPRI”), the Research and Development platform of Fosun Pharma, was awarded with 450,000 USD from the Bill & Melinda Gates Foundation (“Gates Foundation”), a non-profit organization, for the development of a semi-synthetic Artemisinin manufacturing process.Malaria is one of the leading fatal infectious diseases in the world. According ...
Release Date:
2018
-
08
-
23
浏览次数：107